TLSI

TriSalus Life Sciences (TLSI)

About TriSalus Life Sciences (TLSI)

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

Details

Daily high

$7.53

Daily low

$7.11

Price at open

$7.37

52 Week High

$7.70

52 Week Low

$3.42

Market cap

364.7M

Dividend yield

0.00%

Volume

112,067

Avg. volume

184,305

P/E ratio

-3.62

TriSalus Life Sciences News